职位副教授，博士生导师
头像
? ? ? ? 副教授、博导，中山大学“****”引进人才、药剂学学术带头人、广东省特支计划科技创新青年拔尖人才，深圳市高层次领军人才。2011年博士毕业于南开大学化学学院；2012~2014年在清华大学深圳研究生院从事生物学博士后研究；2014年在清华大学深圳研究生院担任讲师；2017-2018年在新加坡南洋理工大学做访问****；2017年11月任中山大学药学院（深圳）“****”副教授、博导。长期从事分子药剂学、生物材料、药物递送系统、生物医药和纳米材料表面修饰等领域的研究。近年来，在Advanced Materials、Advanced Functional Materials、Advanced Science、Biomaterials、ACS Nano、Small和Theranostics等国际知名期刊发表高水平论文60余篇，其中第一/通讯作者论文40余篇。他引次数累积3000余次，个人H-index 32。7篇论文入选高被引论文，多篇论文被选为封面或封底论文。申请国家发明专利12项，授权7项。主持或主持完成国家自然科学基金、广东特支计划科技创新青年拔尖人才项目、广东省自然科学基金和中央高校基本科研业务费重点培育项目等国家和省部级项目10余项。获得深圳市自然科学奖二等奖。获得Acta Biomaterialia和International Journal of Pharmaceutics等多个Elsevier期刊“杰出审稿人”(Outstanding Reviewer)荣誉称号。获得深圳市高层次领军人才和南山区领航人才等荣誉称号。广东省自然科学基金委、深圳市科技创新委和深圳市经贸信息委等部门科技评审专家。ACS Nano、Biomaterials、Small、Journal of Controlled Release等国际知名期刊的长期受邀审稿专家。担任Smart Materials in Medicine编委和Chinese Chemical Letters青年编委。
电子邮箱zengxw23@mail.sysu.edu.cn or xwzeng@163.com
学科专业药剂学
个人经历教育与工作经历
2006年-2011年 ???南开大学, 化学学院, 高分子化学与物理博士
2012年-2014年??? 清华大学, 深圳研究生院, 生物学博士后
2014年-2017年??? 清华大学, 深圳研究生院, 讲师
2017年-2018年??? 新加坡南洋理工大学，访问****
2017年-至今： 中山大学，药学院（深圳），“****”副教授、博导
授课课程
《药剂学》、《药剂学实验》、《药用高分子材料》
研究方向分子药剂学、生物材料和药物递送系统
代表论著[1] Weiwei Zeng, Hanjie Zhang, Yimin Deng, Aiting Jiang, Xiaoyan Bao, Minqi Guo, Zimu Li, Meiying Wu, Xiaoyuan Ji*, Xiaowei Zeng*, Lin Mei*, Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy, Chemical Engineering Journal 389 (2020) 124494
[2] Wei Cheng, Xiaowei Zeng*, Hongzhong Chen, Zimu Li, Wenfeng Zeng, Lin Mei, Yanli Zhao*, Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine, ACS Nano 13 (2019) 8537-8565.
[3] Xiaowei Zeng, Miaomiao Luo, Gan Liu, Xusheng Wang, Wei Tao, Yaoxin Lin, Xiaoyuan Ji, Lin Nie, Lin Mei*, Polydopamine-modified black phosphorous nanocapsule with enhanced stability and photothermal performance for tumor multimodal treatments, Advanced Science 5 (2018), **.?
[4] Shucheng Liu, Jianming Pan*, Jinxin Liu, Yue Ma, Fengxian Qiu, Lin Mei, Xiaowei Zeng*, Guoqing Pan*, Dynamically PEGylated and borate-coordination-polymer-coated polydopamine nanoparticles for synergetic tumor-targeted, chemo-photothermal combination therapy, Small 14 (2018) **.??
[5] Yunmei Peng, Junpeng Nie, Wei Cheng, Gan Liu, Dunwan Zhu*, Linhua Zhang, Chaoyu Liang, Lin Mei, Laiqiang Huang*, Xiaowei Zeng*, A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance, Biomaterials Science 6 (2018) 1084-1098.
[6] Chaoyu Liang, Heping Wang, Min Zhang, Wei Cheng, Zihuang Li*, Junpeng Nie, Gan Liu, Daizheng Lian, Zhenhua Xie, Laiqiang Huang*, Xiaowei Zeng*, Self-controlled release of Oxaliplatin prodrug from d-a-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy, Journal of Colloid and Interface Science 525 (2018) 1-10. (Cover Paper)
[7] Xiaowei Zeng, Gan Liu, Wei Tao, Yue Ma, Xudong Zhang, Fan He, Jianming Pan*, Lin Mei*, Guoqing Pan*, A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond, Advanced Functional Materials 27 (2017) **.? (Cover Paper) ?
[8] Wei Cheng, Junpeng Nie, Nansha Gao, Gan Liu*, Wei Tao, Xiaojun Xiao, Lijuan Jiang, Zhigang Liu, Xiaowei Zeng*, Lin Mei*, A multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy, Advanced Functional Materials 27 (2017) **. ?(Back Cover Paper)
[9] Wei Cheng, Junpeng Nie, Lv Xu, Chaoyu Liang, Yunmei Peng, Gan Liu, Teng Wanga, Lin Mei, Laiqiang Huang*, Xiaowei Zeng*, A pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy, ACS Applied Materials & Interfaces 9 (2017) 18462-18473. ?
[10] Wei Cheng, Chaoyu Liang, Lv Xu, Gan Liu, Nansha Gao, Wei Tao, Lingyan Luo, Yixiong Zuo, Xusheng Wang, Xudong Zhang, Xiaowei Zeng*, and Lin Mei*, TPGS-functionalized polydopamine-modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance, Small 13 (2017) **.? (Back Cover Paper)?
[11] Wei Cheng, Chaoyu Liang, Xusheng Wang, Hsiang-i Tsai, Gan Liu, Yunmei Peng, Junpeng Nie, Laiqiang Huang*, Lin Mei*, Xiaowei Zeng*, A drug-self-gated and tumor microenvironmentresponsive mesoporous silica vehicle: “four-in-one” versatile nanomedicine for targeted multidrug-resistant cancer therapy, Nanoscale 9 (2017) 17063-17073.
[12] Dunwan Zhu, Wei Tao, Hongling Zhang, Gan Liu, Teng Wang, Linhua Zhang, Xiaowei Zeng*, Lin Mei*, Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer, Acta Biomaterialia 30 (2016) 144-154. ?
[13] Danfeng Chang, Yongfeng Gao, Lijun Wang, Gan Liu, Yuhan Chen, Teng Wang, Wei Tao, Lin Mei, Laiqiang Huang*, Xiaowei Zeng*, Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy, Journal of Colloid and Interface Science 463 (2016) 279-287.
[14] Xiaowei Zeng, Wei Tao, Zhongyuan Wang, Xudong Zhang, Huijun Zhu, Yanping Wu, Yongfeng Gao, Kewei Liu, Yuyang Jiang, Laiqiang Huang, Lin Mei*, Si-Shen Feng*, Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA-b -TPGS for cancer treatment, Particle & Particle Systems Characterization 32 (2015) 112-122.
[15] Wei Tao, Jinxie Zhang, Xiaowei Zeng*, Danny Liu, Gan Liu, Xi Zhu, Yanlan Liu, Qingtong Yu, Laiqiang Huang*, Lin Mei*, Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy, Advanced Healthcare Materials 4 (2015) 1203-1214. ?(Back Cover Paper)
[16] Xiaowei Zeng, Wei Tao, Lin Mei*, Laiqiang Huang, Chunyan Tan, Si-Shen Feng*, Cholic acid-functionalized nanoparticles of star-shaped PLGA-Vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 34 (2013) 6058-6067.
?
